Clinical trial
Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy
NCT02351531 is registered in ClinicalTrials.gov with United Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy
- Lead sponsor
- United Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- Not reported
- Enrollment
- 32 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cow milk allergy